Mangalam Drugs And Organics Limited (MANGALAM) — Insider Trading
Mangalam Drugs and Organics Limited announced a trading window closure for designated persons and their immediate relatives from April 1, 2026 until 48 hours after declaration of FY2026 audited financial statements. This is a routine regulatory measure under SEBI's insider trading prohibition framework, implemented ahead of the company's annual results announcement to prevent information-based trading.
About Mangalam Drugs And Organics Limited (MANGALAM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when MANGALAM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track MANGALAM — Free💡 Ask AI about this filing
📊 More MANGALAM filings
- share transfer — 13 July 2026 Mangalam Drugs and Organics Limited received a compliance certificate from MUFG Intime India Private...
- 🔴 Announcement — 17 June 2026 No summary available
- 🔴 Announcement — 17 June 2026 No summary available
- 🔴 Announcement — 16 May 2026 Mangalam Drugs and Organics Limited disclosed a loan default exceeding 30 days on obligations to Ban...
- 🔴 Announcement — 21 April 2026 No summary available
🔥 Also filed on 24 March 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when MANGALAM files new disclosures
Track MANGALAM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MANGALAM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research